Osmolarity determines the in vitro chondrogenic differentiation capacity of progenitor cells via nuclear factor of activated T-cells 5

Bone

Volumn 53, Issue 1, 2013, Pages 94-102

  Caron, Marjolein M J ^a   van der Windt, Anna E ^b   Emans, Pieter J ^a   van Rhijn, Lodewijk W ^a   Jahr, Holger ^b   Welting, Tim J M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Chondrogenic differentiation; Nfat5; Osmolarity; Progenitor cells; Sox9

Indexed keywords

AGGRECAN; CELL MARKER; GLYCOSAMINOGLYCAN; MESSENGER RNA; NUCLEAR FACTOR OF ACTIVATED T CELL 5; PROTEIN COL10A1; PROTEIN COL2A1; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

AGGRECAN GENE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CHONDROGENESIS; COL10A1 GENE; COL2A1 GENE; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE INDUCTION; GENE SILENCING; GENETIC ANALYSIS; GLYCOSAMINOGLYCAN GENE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HYPEROSMOLARITY; IN VITRO STUDY; MARKER GENE; MESENCHYMAL STEM CELL; NUCLEAR FACTOR OF ACTIVATED T CELL 5 GENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATOR GENE; RNA INTERFERENCE; TRANSCRIPTION FACTOR RUNX2 GENE; TRANSCRIPTION FACTOR SOX9 GENE; TRANSCRIPTION REGULATION;

BASE SEQUENCE; CARTILAGE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; DNA PRIMERS; HUMANS; OSMOLAR CONCENTRATION; POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STEM CELLS; TRANSCRIPTION FACTORS;

EID: 84871645961     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.11.032     Document Type: Article

References (42)

1. Kronenberg H.M. Developmental regulation of the growth plate. Nature 2003, 423:332-336.
2. Mackie E.J., Ahmed Y.A., Tatarczuch L., Chen K.S., Mirams M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol 2008, 40:46-62.
3. Zuscik M.J., Hilton M.J., Zhang X., Chen D., O'Keefe R.J. Regulation of chondrogenesis and chondrocyte differentiation by stress. J Clin Invest 2008, 118:429-438.
4. de Crombrugghe B., Lefebvre V., Nakashima K. Regulatory mechanisms in the pathways of cartilage and bone formation. Curr Opin Cell Biol 2001, 13:721-727.
5. Lefebvre V., Smits P. Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today 2005, 75:200-212.
6. Mow V.C., Atheshian G.A. Lubrication and wear of diarthrodial joints. Basic orthopaedic biomechanics 1997, 275-315. Lippincott-Raven, Philidelphia (PA). V.C. Mow, W.C. Hayes (Eds.).
7. Lesperance L.M., Gray M.L., Burstein D. Determination of fixed charge density in cartilage using nuclear magnetic resonance. J Orthop Res 1992, 10:1-13.
8. Venn M., Maroudas A. Chemical composition and swelling of normal and osteoarthrotic femoral head cartilage. I. Chemical composition. Ann Rheum Dis 1977, 36:121-129.
9. Urban J.P. The chondrocyte: a cell under pressure. Br J Rheumatol 1994, 33:901-908.
10. Urban J.P., Hall A.C., Gehl K.A. Regulation of matrix synthesis rates by the ionic and osmotic environment of articular chondrocytes. J Cell Physiol 1993, 154:262-270.
11. Bhalla A., Sankaralingam S., Dundas R., Swaminathan R., Wolfe C.D., Rudd A.G. Influence of raised plasma osmolality on clinical outcome after acute stroke. Stroke 2000, 31:2043-2048.
12. Charkoudian N., Eisenach J.H., Joyner M.J., Roberts S.K., Wick D.E. Am J Physiol Heart Circ Physiol 2005, 289:H2456-H2460.
13. Palmer G.D., Chao Ph P.H., Raia F., Mauck R.L., Valhmu W.B., Hung C.T. Time-dependent aggrecan gene expression of articular chondrocytes in response to hyperosmotic loading. Osteoarthritis Cartilage 2001, 9:761-770.
14. van der Windt A.E., Haak E., Das R.H., Kops N., Welting T.J., Caron M.M., et al. Physiological tonicity improves human chondrogenic marker expression through nuclear factor of activated T-cells 5 in vitro. Arthritis Res Ther 2010, 12:R100.
15. van der Windt A.E., Haak E., Kops N., Verhaar J.A., Weinans H., Jahr H. Inhibiting calcineurin activity under physiologic tonicity elevates anabolic but suppresses catabolic chondrocyte markers. Arthritis Rheum 2012, 64:1929-1939.
16. Miyakawa H., Woo S.K., Dahl S.C., Handler J.S., Kwon H.M. Tonicity-responsive enhancer binding protein, a Rel-like protein that stimulates transcription in response to hypertonicity. Proc Natl Acad Sci U S A 1999, 96:2538-2542.
17. Lopez-Rodriguez C., Antos C.L., Shelton J.M., Richardson J.A., Lin F., Novobrantseva T.I., et al. Loss of NFAT5 results in renal atrophy and lack of tonicity-responsive gene expression. Proc Natl Acad Sci U S A 2004, 101:2392-2397.
18. Na K.Y., Woo S.K., Lee S.D., Kwon H.M. Silencing of TonEBP/NFAT5 transcriptional activator by RNA interference. J Am Soc Nephrol 2003, 14:283-288.
19. Chen M., Sastry S.K., O'Connor K.L. Src kinase pathway is involved in NFAT5-mediated S100A4 induction by hyperosmotic stress in colon cancer cells. Am J Physiol Cell Physiol 2011, 300:C1155-C1163.
20. Chen M., Sinha M., Luxon B.A., Bresnick A.R., O'Connor K.L. Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin. J Biol Chem 2009, 284:1484-1494.
21. Woo S.K., Lee S.D., Kwon H.M. TonEBP transcriptional activator in the cellular response to increased osmolality. Pflugers Arch 2002, 444:579-585.
22. Halterman J.A., Kwon H.M., Wamhoff B.R. Tonicity-independent regulation of the osmosensitive transcription factor TonEBP (NFAT5). Am J Physiol Cell Physiol 2012, 302:C1-C8.
23. Yoon H.J., You S., Yoo S.A., Kim N.H., Kwon H.M., Yoon C.H., et al. NFAT5 is a critical regulator of inflammatory arthritis. Arthritis Rheum 2011, 63:1843-1852.
24. Jauliac S., Lopez-Rodriguez C., Shaw L.M., Brown L.F., Rao A., Toker A. The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol 2002, 4:540-544.
25. Schallmoser K., Rohde E., Reinisch A., Bartmann C., Thaler D., Drexler C., et al. Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C Methods 2008, 14:185-196.
26. Caron M.M., Emans P.J., Surtel D.A., Cremers A., Voncken J.W., Welting T.J., et al. Activation of NF-kappaB/p65 facilitates early chondrogenic differentiation during endochondral ossification. PLoS One 2012, 7:e33467.
27. Welting T.J., Caron M.M., Emans P.J., Janssen M.P., Sanen K., Coolsen M.M., et al. Inhibition of cyclooxygenase-2 impacts chondrocyte hypertrophic differentiation during endochondral ossification. Eur Cell Mater 2011, 22:420-436. [discussion 436-7].
28. Atsumi T., Miwa Y., Kimata K., Ikawa Y. A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ Dev 1990, 30:109-116.
29. Chen L., Fink T., Zhang X.Y., Ebbesen P., Zachar V. Quantitative transcriptional profiling of ATDC5 mouse progenitor cells during chondrogenesis. Differentiation 2005, 73:350-363.
30. Barry F.P., Murphy J.M. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 2004, 36:568-584.
31. Aramburu J., Drews-Elger K., Estrada-Gelonch A., Minguillon J., Morancho B., Santiago V., et al. Regulation of the hypertonic stress response and other cellular functions by the Rel-like transcription factor NFAT5. Biochem Pharmacol 2006, 72:1597-1604.
32. Christoph K., Beck F.X., Neuhofer W. Osmoadaptation of mammalian cells - an orchestrated network of protective genes. Curr Genomics 2007, 8:209-218.
33. Racz B., Reglodi D., Fodor B., Gasz B., Lubics A., Gallyas F., et al. Hyperosmotic stress-induced apoptotic signaling pathways in chondrocytes. Bone 2007, 40:1536-1543.
34. Ho S.N. The role of NFAT5/TonEBP in establishing an optimal intracellular environment. Arch Biochem Biophys 2003, 413:151-157.
35. Maouyo D., Kim J.Y., Lee S.D., Wu Y., Woo S.K., Kwon H.M. Mouse TonEBP-NFAT5: expression in early development and alternative splicing. Am J Physiol Renal Physiol 2002, 282:F802-F809.
36. O'Connor R.S., Mills S.T., Jones K.A., Ho S.N., Pavlath G.K. A combinatorial role for NFAT5 in both myoblast migration and differentiation during skeletal muscle myogenesis. J Cell Sci 2007, 120:149-159.
37. Tew S., Peffers M., McKay T., Lowe E., Khan W., Hardingham T., et al. Hyperosmolarity regulates SOX9 mRNA post transcriptionally in human articular chondrocytes. Am J Physiol Cell Physiol 2009, 297:C898-C906.
38. Tew S.R., Hardingham T.E. Regulation of SOX9 mRNA in human articular chondrocytes involving p38 MAPK activation and mRNA stabilization. J Biol Chem 2006, 281:39471-39479.
39. Ko B.C., Lam A.K., Kapus A., Fan L., Chung S.K., Chung S.S. Fyn and p38 signaling are both required for maximal hypertonic activation of the osmotic response element-binding protein/tonicity-responsive enhancer-binding protein (OREBP/TonEBP). J Biol Chem 2002, 277:46085-46092.
40. Lee J.H., Kim M., Im Y.S., Choi W., Byeon S.H., Lee H.K. NFAT5 induction and its role in hyperosmolar stressed human limbal epithelial cells. Invest Ophthalmol Vis Sci 2008, 49:1827-1835.
41. Morancho B., Minguillon J., Molkentin J.D., Lopez-Rodriguez C., Aramburu J. Analysis of the transcriptional activity of endogenous NFAT5 in primary cells using transgenic NFAT-luciferase reporter mice. BMC Mol Biol 2008, 9:13.
42. Emans P.J., van Rhijn L.W., Welting T.J., Cremers A., Wijnands N., Spaapen F., et al. Autologous engineering of cartilage. Proc Natl Acad Sci U S A 2010, 107:3418-3423.